Minor
DCCR · Prader-Willi Syndrome
Trial completed
Also in this update: Primary completion date changed from estimate of Jun 2028 to Jan 12, 2026
Soleno Therapeutics, Inc.Phase 3 NCT05701774 Registry history of NCT05701774 on ClinicalTrials.gov (opens the registry)